P. Neven

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study

Holger Eidtmann, Richard de Boer, Nigel Bundred et al. · Annals of Oncology · 2010 · 280 citations

Medicine, Oncology, Pharmacotherapy +15

Update on triple-negative breast cancer: prognosis and management strategies

P. Neven, Brouckaert, Wildiers et al. · International Journal of Women s Health · 2012 · 141 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Utility of prognostic genomic tests in breast cancer practice: The IMPAKT 2012 Working Group Consensus Statement

Hatem A. Azim, Stefan Michiels, Flora Zagouri et al. · Annals of Oncology · 2013 · 132 citations · Full text

Medicine, Genetics, Oncology +17

Primary invasive mucinous ovarian carcinoma of the intestinal type: Importance of the expansile versus infiltrative type in predicting recurrence and lymph node metastases

Kristof Muyldermans, Ph. Moerman, Frédéric Amant et al. · European Journal of Cancer · 2013 · 80 citations

Medicine, Oncology, Surgery +15

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Guy Jérusalem, Gabriella Mariani, Eva Ciruelos et al. · Annals of Oncology · 2016 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17